Anemia, a prevalent condition characterized by a decrease in the number of red blood cells or less than the normal quantity of hemoglobin in the blood, presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive diagnostic approach to anemia in clinical practice.
The initial evaluation of anemia should include a thorough patient history and physical examination. The history should focus on potential causes such as dietary habits, family history, and symptoms like fatigue, pallor, or dyspnea. The physical examination should assess for signs of systemic diseases which could contribute to anemia.
Basic laboratory investigations should include a complete blood count (CBC) with peripheral smear, reticulocyte count, and serum ferritin. More specific tests such as Vitamin B12, folate levels, or hemoglobin electrophoresis may be indicated based on initial findings. An elevated red cell distribution width (RDW) can indicate a mixed cause of anemia or an early stage of a developing anemia.
Further diagnostic refinement should be guided by the initial investigations. Microcytic anemia may indicate iron deficiency, thalassemia, or anemia of chronic disease. Normocytic anemia could be due to renal disease, malignancy, or aplastic anemia. Macrocytic anemia might suggest Vitamin B12 or folate deficiency, myelodysplastic syndrome, or alcoholism. Bone marrow examination may be necessary in cases of unexplained anemia.
Anemia is a complex disorder with a broad differential diagnosis. A systematic approach that includes a thorough history, physical examination, and appropriate laboratory investigations can help clinicians navigate this complexity. Ongoing research into the pathophysiology of anemia continues to inform and refine our diagnostic approach, promising more precise and personalized care for patients with this common condition.
1.
Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit
2.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
3.
SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control
4.
Breast Cancer Genetic Testing Need in Black Women Identified
5.
Preoperative Embolization Linked to Relapse-Free Survival in Meningioma
1.
ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring
2.
Pediatric Cancer Cell Line Authentication and Reproducibility
3.
Surgical Innovation Using Hematopoietic Reserve Preservation During Major Surgery
4.
3D Genome Reorganization in Cancer Cells: Mechanisms, Clinical Implications, and Emerging Therapeutic Frontiers
5.
Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
2.
Thromboprophylaxis In Medical Settings
3.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
5.
Predicting Delayed Hemolytic Transfusion Reactions Through Donor-Recipient Antigen Exposure Modeling
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation